Simon Berry
@Simon_Berry_
Followers
41
Following
52
Media
1
Statuses
16
Clinical Research Fellow in Diabetes, University of Sheffield; Specialty Registrar in Diabetes and Endocrine
Sheffield, England
Joined July 2017
Clinical Fellowship in Diabetes Technology @youngdiabendo @DTN_UK @Leicester Diabetes @LDC_tweets looking for diabetes reg who wants a year with us to gain expertise in diabetes technology - drop me a line if u r interested
1
31
47
During the ADA, I had the opportunity to speak to HCL Live regarding our retrospective study of the use of tirzepatide in type 1 diabetes, link below!
We spoke with @Simon_Berry_ about promising findings from a retrospective, real-world study of tirzepatide for type 1 #diabetes that should be confirmed in RCTs at #ADASciSessions. Watch now: https://t.co/4gEQz3xS6b
0
1
4
Pleased to share our real world study which shows that insulin pumps ⬇️ all-cause mortality & DKA risk compared to multiple daily injections. Read full open access article here: https://t.co/NxnH910lDB
@Ahmed742Iqbal @Simon_Berry_
dom-pubs.onlinelibrary.wiley.com
Aims Clinical trials have demonstrated the benefits of insulin pump therapy compared with multiple daily injections (MDI) in type 1 diabetes. However, contemporaneous real-world data are limited....
0
4
4
Registration for the YDEF Technology Course delivered by DTN-UK 22-24th July is now open. Sign up quickly to avoid disappointment! https://t.co/zqAwJOEm6F
1
1
2
📢 New study from our group: Hypoglycaemia in T1D with impaired awareness causes proarrhythmogenic ECG changes, with intra- & inter-individual variability. https://t.co/wgmeXkX9jQ
#Hypoglycaemia #ECG @diabmedwiley @sheffielduni @DUK_research
onlinelibrary.wiley.com
Aims Hypoglycaemia causes abnormal cardiac repolarisation, which has been related to sympathoadrenal activation. We examined whether individuals with type 1 diabetes (T1D) and impaired awareness of...
2
15
30
Members of the YDEF committee at the #DUKPC25! A week of learning about incredible advances in diabetes care! We are looking forward to the #sfebes2025 conference in a couple of weeks! @ABCDiab @Soc_Endo @DiabetesUK
1
7
33
@drpratikc @WilmotEmma @Ahmed742Iqbal @Alex_Liarakos We try to answer: 1. What is the current prevalence of IAH? 2. Can we still use the Gold and Clarke scores? Are there any better questionnaire methods? 3. Can we use CGM metrics such as TBR to diagnose IAH?
0
3
8
How do you assess impaired awareness of hypoglycaemia in the CGM era? Excited to present our narrative review, published today in DOM. Great collaboration with @drpratikc @WilmotEmma @Ahmed742Iqbal @Alex_Liarakos and Vaios Koutroukas. https://t.co/1gSKP2i0JP
dom-pubs.onlinelibrary.wiley.com
Iatrogenic hypoglycaemia remains a major barrier in diabetes care. Over time, and with repeated hypoglycaemic episodes, the physiological responses to hypoglycaemia can become blunted, resulting in...
1
11
22
Join us for the inaugural YDEF-UKINETS training meeting on 11/02/2025 from 14.00-16.30 on MS-Teams. Abstracts for case presentations are welcome! Sign-up here: https://t.co/zMsKV6BNVu
@UKINETS @Soc_Endo @DiabetesUK
0
4
3
Save the date 📆 Our next YDEF-DTN tech course will be running 9-11th October 2024 in Loughborough Registration will open 21st August via the below link 👇 it will only open at 9am that day. https://t.co/n9Kj8zT4MO Any questions just let us know! @DTN_UK
forms.office.com
1
3
6
Calling all D&E SpRs. We need your help! We are creating a starter pack to help new SpRs settle in and have a better idea of what D&E training is all about. Please fill in the survey to give your top tips of what to do (/what not to do!) 👇 https://t.co/2coesPv66G
surveymonkey.com
YDEF survey for starting specialist D and E training
0
11
6
Read our latest publication in @SpringerNature reporting results from 🇬🇧 Endocrinologists' survey on Hypertonic Saline https://t.co/zUiihQrbWH *⃣ Most clinicians adopt cautious approach in repeating boluses *⃣ Monitoring VBG sodium➡️Useful *⃣ Research & guidelines update needed
1
6
16
Excited to be in Boston at #ENDO24 to present our work looking at the outcomes of metyrapone for MACS. Thank you to Prof Debono, Prof Newell-Price and @Ahmed742Iqbal!
2
4
15